Industry News
Pharmaceutical Industry News
JPM 2022: Vertex’s Trikafta holds the line as company lays groundwork for gene editing launch
JPM 2022: Vertex's Trikafta holds the line as company lays groundwork for gene editing launch fkansteiner Mon, 01/10/2022 - 10:54
Merck, eyes on Roche’s immunotherapy first, returns perplexing Keytruda post-surgery lung cancer data
Merck, eyes on Roche’s immunotherapy first, returns perplexing Keytruda post-surgery lung cancer data aliu Mon, 01/10/2022 - 09:43
Recipharm unloads a pair of plants in separate deals as part of its streamlining, growth strategy
Recipharm unloads a pair of plants in separate deals as part of its streamlining, growth strategy jkeenan Mon, 01/10/2022 - 08:46
Eyeing its post-Humira future, AbbVie angles for broader Rinvoq use in U.S., Europe
Eyeing its post-Humira future, AbbVie angles for broader Rinvoq use in U.S., Europe fkansteiner Mon, 01/10/2022 - 08:42
Idorsia scores FDA go-ahead for insomnia drug Quviviq to rival Merck’s Belsomra, Eisai’s Dayvigo
Idorsia scores FDA go-ahead for insomnia drug Quviviq to rival Merck's Belsomra, Eisai's Dayvigo kdunleavy Mon, 01/10/2022 - 08:09
#JPM22, Day 1: Bristol Myers Squibb’s blockbuster losses of exclusivity, Novartis’ spending plans and more
#JPM22, Day 1: Bristol Myers Squibb's blockbuster losses of exclusivity, Novartis' spending plans and more esagonowsky Mon, 01/10/2022 - 07:30
UPDATED: JPM22, Day 1: Merck’s COVID antiviral, Novartis’ spending plans, Pfizer’s COVID production and more
UPDATED: JPM22, Day 1: Merck's COVID antiviral, Novartis' spending plans, Pfizer's COVID production and more esagonowsky Mon, 01/10/2022 - 07:30
Red often means stop in new glaucoma survey from Bausch + Lomb
Red often means stop in new glaucoma survey from Bausch + Lomb sharon.coey Mon, 01/10/2022 - 07:16
How can pharma engage with caregivers? Try programs that ease their stress
How can pharma engage with caregivers? Try programs that ease their stress nmissakian Sun, 01/09/2022 - 19:20
The drive to digital in pharma marketing is ‘overwhelming’ doctors. Solution? Train digitally savvy reps
The drive to digital in pharma marketing is 'overwhelming' doctors. Solution? Train digitally savvy reps badams Sat, 01/08/2022 - 12:50
Catalent FDA write-up ‘allegedly’ the culprit behind Novo Nordisk’s Wegovy supply woes: report
Catalent FDA write-up 'allegedly' the culprit behind Novo Nordisk's Wegovy supply woes: report fkansteiner Fri, 01/07/2022 - 16:27
Catalent’s FDA write-up spurred Novo Nordisk’s Wegovy supply woes
Catalent's FDA write-up spurred Novo Nordisk's Wegovy supply woes fkansteiner Fri, 01/07/2022 - 16:27
CEO pay for Pfizer, J&J, Moderna and AstraZeneca should be tied to COVID-19 vaccine equity, investors say
CEO pay for Pfizer, J&J, Moderna and AstraZeneca should be tied to COVID-19 vaccine equity, investors say aliu Fri, 01/07/2022 - 11:05
Merck’s Keytruda scores key NICE sign-off for first-line NSCLC indication
Merck's Keytruda scores key NICE sign-off for first-line NSCLC indication kdunleavy Fri, 01/07/2022 - 10:02
FDA must hit the gas on FOIA request tied to Pfizer’s COVID-19 vaccine, judge orders
FDA must hit the gas on FOIA request tied to Pfizer's COVID-19 vaccine, judge orders fkansteiner Fri, 01/07/2022 - 09:23
Say what you see: Novavax taps its own branding for latest COVID vaccine
Say what you see: Novavax taps its own branding for latest COVID vaccine badams Fri, 01/07/2022 - 09:15
Regeneron hands over Evkeeza rights to Ultragenyx outside US, with an R&D asset also thrown in
Regeneron hands over Evkeeza rights to Ultragenyx outside US, with an R&D asset also thrown in badams Fri, 01/07/2022 - 08:55
Fierce Pharma Asia—Samsung and Biogen rumors; Novartis-BeiGene TIGIT deal; Aduhelm’s Japan defeat
Fierce Pharma Asia—Samsung and Biogen rumors; Novartis-BeiGene TIGIT deal; Aduhelm's Japan defeat aliu Fri, 01/07/2022 - 06:24
Blueprint’s Ayvakit launch ramps up as it taps LabCorp, new education campaign to boost awareness
Blueprint's Ayvakit launch ramps up as it taps LabCorp, new education campaign to boost awareness badams Fri, 01/07/2022 - 05:27
Covid Treatments Including Paxlovid Are Rationed as Cases Spike
Scarce supplies and surging Covid cases have caused health officials, hospitals, doctors and patients to scramble for pills and infusions.